Photoprotection of the future: challenges and opportunities.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
26
08
2019
accepted:
17
10
2019
pubmed:
4
1
2020
medline:
5
1
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
The use of sunscreens is an important and essential component of photoprotection. Since their introduction during the first half of the last century, sunscreens have benefited enormously from major technological advances such as the development of novel UV filters; as a result, their efficacy in preventing UV-induced erythema is unequivocal. More recently, however, new challenges have appeared, which have prompted a robust discussion about the safety of sunscreens. These include topics directly related to photoprotection of human skin such as improved/alternative methods for standardization of assessment of the efficacy of sunscreens, but also many others such as photoprotection beyond UV, concerns about human toxicity and ecological safety, the potential of oral photoprotective measures, consequences of innovative galenic formulations. On a first glance, some of these might raise questions and doubts among dermatologists, physicians and the general public about the use sunscreens as a means of photoprotection. This situation has prompted us to critically review such challenges, but also opportunities, based on existing scientific evidence. We conclude by providing our vision about how such challenges can be met best in the future in an attempt to create the ideal sunscreen, which should provide adequate and balanced protection and be easy and safe to use.
Substances chimiques
Sunscreening Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
447-454Informations de copyright
© 2020 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Svarc F. A brief illustrated history on sunscreens and sun protection. Pure Appl Chem 2015; 87: 929-936.
van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 2546-2548.
Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. JAMA Dermatol 2003; 139: 451-455.
Hirst NG, Gordon LG, Scuffham PA, Green AC. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value Health 2012; 15: 261-268.
van der Pols JC, Williams GM, Pandeya N, Logan V, Green AC. Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 2006; 15: 2546-2548.
Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 2011; 29: 257-263.
Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 2000; 23(Suppl 1): S22-S26.
Wolber R, Schlenz K, Wakamatsu K et al. Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res 2008; 21: 487-491.
Robinson JD, Silk KJ, Parrott RL, Steiner C, Morris SM, Honeycutt C. Healthcare providers’ sun-protection promotion and at-risk clients’ skin-cancer-prevention outcomes. Prev Med 2004; 38: 251-257.
Osterwalder U, Herzog B. Sun protection factors: world wide confusion. Br J Dermatol 2009; 161(Suppl 3): 13-24.
Trullàs C, Granger C, Lim HW, Krutmann J, Masson P. Linear and exponential sunscreen behaviours as an explanation for observed discrepancies in sun protection factor testing. Photodermatol Photoimmunol Photomed 2019. [Epub ahead of print]. https://doi.org/10.1111/phpp.12500
Damian DL, Halliday GM, Stc Barnetson R. Sun protection factor measurement of sunscreens is dependent on minimal erythema dose. Br J Dermatol 1999; 141: 502-507.
Schalka S, Reis VM. Sun protection factor: meaning and controversies. An Bras Dermatol 2011; 86: 507-515.
Rohr M, Ernst N, Schrader A. Hybrid diffuse reflectance spectroscopy: non-erythemal in vivo testing of sun protection factor. Skin Pharmacol Physiol 2018; 31: 220-228.
Williams JD, Maitra P, Atillasoy E, Wu MM, Farberg AS, Rigel DS. SPF 100+ sunscreen is more protective against sunburn than SPF 50+ in actual use: results of a randomized, double-blind, split-face, natural sunlight exposure clinical trial. J Am Acad Dermatol 2018; 78: 902-910.e2.
Ou-Yang H, Stanfield J, Cole C, Appa Y, Rigel D. High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. J Am Acad Dermatol 2012; 67: 1220-1227.
Schalka S, Steiner D, Ravelli FN et al. Brazilian consensus on photoprotection. An Bras Dermatol 2014; 89(6 Suppl 1): 1-74.
Autier P, Doré JF. Ultraviolet radiation and cutaneous melanoma: a historical perspective. Melanoma Res 2019. [Epub ahead of print]. https://doi.org/10.1097/cmr.0000000000000609
Battie C, Jitsukawa S, Bernerd F, Del Bino S, Marionnet C, Verschoore M. New insights in photoaging, UVA induced damage and skin types. Exp Dermatol 2014; 23(Suppl 1): 7-12.
Mahmoud BH, Ruvolo E, Hexsel CL et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 2010; 130: 2092-2097.
Kohli I, Chaowattanapanit S, Mohammad TF et al. Synergistic effects of long-wavelength ultraviolet al and visible light on pigmentation and erythema. Br J Dermatol 2018; 178: 1173-1180.
Duteil L, Cardot-Leccia N, Queille-Roussel C et al. Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res 2014; 27: 822-826.
Regazzetti C, Sormani L, Debayle D et al. Melanocytes sense blue light and regulate pigmentation through opsin-3. J Invest Dermatol 2018; 138: 171-178.
Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res 2018; 31: 461-465.
Passeron T, Nouveau S, Duval C et al. Development and validation of a reproducible model for studying post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res 2018; 31: 649-652.
Boukari F, Jourdan E, Fontas E et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol 2015; 72: 189-190.e1.
Duteil L, Esdaile J, Maubert Y et al. A method to assess the protective efficacy of sunscreens against visible light-induced pigmentation. Photodermatol Photoimmunol Photomed 2017; 33: 260-266.
Schalka S. New data on hyperpigmentation disorders. J Eur Acad Dermatol Venereol 2017; 31(Suppl 5): 18-21.
Schroeder P, Lademann J, Darvin ME et al. Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection. J Invest Dermatol 2008; 128: 2491-2497.
Grether-Beck S, Marini A, Jaenicke T, Krutmann J. Effective photoprotection of human skin against infrared A radiation by topically applied antioxidants: results from a vehicle controlled, double-blind, randomized study. Photochem Photobiol 2015; 91: 248-250.
Diffey BL, Brown MW. The ideal spectral profile of topical sunscreens. Photochem Photobiol 2012; 88: 744-747.
Boukari F, Jourdan E, Fontas E et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol 2015; 72: 189-190.e1.
Passeron T. The key question of irradiance when it comes to the effects of visible light in the skin. J Dermatol Sci 2019; 93: 69-70.
Schieke SM, Ruwiedel K, Gers-Barlag H, Grether-Beck S, Krutmann J. Molecular crosstalk of the ultraviolet a and ultraviolet B signaling responses at the level of mitogen-activated protein kinases. J Invest Dermatol 2005; 124: 857-859.
Rigel DS, Rigel EG, Rigel AC. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999; 40: 114-116.
Granger C, Krutmann J, Bustos J et al. New methodology to evaluate sunscreens under outdoor conditions: a double-blind, randomized intra-individual clinical study of a water-based broad-spectrum SPF50+ versus SPF15 (P3) and SPF50. Dermatol Ther (Heidelb) 2019; 9: 589-599.
Matta MK, Zusterzeel R, Pilli NR et al. Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA 2019; 321: 2082-2091.
Osmond-McLeod MJ, Oytam Y, Rowe A et al. Long-term exposure to commercially available sunscreens containing nanoparticles of TiO2 and ZnO revealed no biological impact in a hairless mouse model. Part Fibre Toxicol 2016; 13: 44.
Nohynek GJ, Dufour EK. Nano-sized cosmetic formulations or solid nanoparticles in sunscreens: a risk to human health? Arch Toxicol 2012; 86: 1063-1075.
Schneider SL, Lim HW. A review of inorganic UV filters zinc oxide and titanium dioxide. Photodermatol Photoimmunol Photomed 2018; 35: 442-446. Review.
Passeron T, Bouillon R, Callender V et al. Sunscreen photoprotection and vitamin D status. Br J Dermatol 2019; 181: 916-931.
Neale RE, Khan SR, Lucas RM, Waterhouse M, Whiteman DC, Olsen CM. The effect of sunscreen on vitamin D: a review. Br J Dermatol 2019; 181: 907-915.
Cranwell WC, Sinclair R. Sunscreen and facial skincare products in frontal fibrosing alopecia: a case-control study. Br J Dermatol 2019; 180: 943-944.
Moreno-Arrones OM, Saceda-Corralo D, Rodrigues-Barata AR et al. Risk factors associated with frontal. fibrosing alopecia: a multicentre case-control study. Clin Exp Dermatol 2019; 44: 404-410.
Draelos ZD. Compliance and sunscreens. Dermatol Clin 2006; 24: 101-104.
Wang SQ, Virmani P, Lim HW. Consumer acceptability and compliance: the next frontier in sunscreen innovation. Photodermatol Photoimmunol Photomed 2016; 32: 55-56.
Narda M, Ramos-Lopez D, Mun G, Valderas-Martinez P, Granger C. Three-tier testing approach for optimal ocular tolerance sunscreen. Cutan Ocul Toxicol 2019; 7: 1-9.
Mitchelmore CL, He K, Gonsior M et al. Occurrence and distribution of UV-filters and other anthropogenic contaminants in coastal surface water, sediment, and coral tissue from Hawaii. Sci Total Environ 2019; 20: 398-410.
Schneider SL, Lim HW. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol 2019; 80: 266-271.
Surjana D, Halliday GM, Martin AJ, Moloney FJ, Damian DL. Oral nicotinamide reduces actinic keratoses in phase II double-blinded randomized controlled trials. J Invest Dermatol 2012; 132: 1497-1500.
Chen AC, Damian DL, Halliday GM. Oral and systemic photoprotection. Photodermatol Photoimmunol Photomed 2014; 30: 102-111.
Köpcke W, Krutmann J. Protection from sunburn with beta-carotene - a meta-analysis. Photochem Photobiol 2008; 84: 284-288.
Kohli I, Shafi R, Isedeh P et al. The impact of oral polypodium leucotomos extract on ultraviolet B response: a human clinical study. J Am Acad Dermatol 2017; 77: 33-41.
Grether-Beck S, Marini A, Jaenicke T, Stahl W, Krutmann J. Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study. Br J Dermatol 2017; 176: 1231-1240.
Cadet J, Douki T. Formation of UV-induced DNA damage contributing to skin cancer development. Photochem Photobiol Sci 2018; 17: 1816-1841.
Langendonk JG, Balwani M, Anderson KE et al. Afamelanotide for erythropoietic protoporphyria. N Engl J Med 2015; 373: 48-59.
Delinasios GJ, Karbaschi M, Cooke MS, Young AR. Vitamin E inhibits the UVAI induction of “light” and “dark” cyclobutane pyrimidine dimers, and oxidatively generated DNA damage, in keratinocytes. Sci Rep 2018; 8: 423.
Yamaguchi Y, Takahashi K, Zmudzka BZ et al. Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. FASEB J 2006; 20: 1486-1488.